C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/30 (2006.01) A61K 39/395 (2006.01) C12N 5/20 (2006.01) C12N 15/13 (2006.01)
Patent
CA 2525251
The present invention provides monoclonal antibodies and antigen-binding fragments thereof that specifically bind to CD20, as well as pharmaceutical compositions comprising the same. The invention further provides methods of using the monoclonal antibodies, antigen-binding fragments, and pharmaceutical compositions, for example, in methods of depleting B cells or in treating B cell disorders. Also provided are cells, nucleic acids and methods for producing the monoclonal antibodies.
L'invention concerne des anticorps monoclonaux et leurs fragments de liaison à l'antigène qui se lient spécifiquement à CD20 ainsi que des compositions pharmaceutiques comprenant lesdits éléments. L'invention concerne également des méthodes d'utilisation desdits anticorps monoclonaux, fragments de liaison à l'antigène et compositions pharmaceutiques, par exemple, dans des méthodes de déplétion des lymphocytes B ou dans le traitement des troubles des lymphocytes B. L'invention concerne également des cellules, des acides nucléiques et des méthodes de production desdits anticorps monoclonaux.
Hamaguchi Yasuhito
Poe Jonathan C.
Tedder Thomas F.
Uchida Junji
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Duke University
Hamaguchi Yasuhito
Poe Jonathan C.
Tedder Thomas F.
LandOfFree
Cd20-specific antibodies and methods of employing same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cd20-specific antibodies and methods of employing same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cd20-specific antibodies and methods of employing same will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1934767